தீபக் கார்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Sany becomes No 1 in Excavators Sales Globally
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Sany Becomes No 1 in Excavators Sales Globally
cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.
Accreditation to gear up for challenges on NEP s implementation: says NBA Chairman
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Sany India launches COVID Care Helpline Number ANI | Updated: Jun 03, 2021 18:56 IST
Pune (Maharashtra) [India], June 3 (ANI/NewsVoir): Sany India, a leading manufacturer of construction equipment, heavy machinery and renewable energy solutions has been consistently stepping up their efforts to fight the pandemic through innovative measures and preventive care.
The company recently launched a COVID Care helpline number for all their employees, customers, dealers, dealer employees and workers along with their family members. The helpline which will be active from 9 AM to 9 PM on all days will be manned by Sany India contact centre and is equipped to provide fast access to medical experts and much more.
Oxford Biomedica shares surge after it raises its forecast for COVID-19 vaccine revenues
A look at the major movers on the London market on Tuesday
Oxford Biomedica PLC (LON:OXB) has been boosted by vaccine news.
The company, a key manufacturer of the Oxford/AstraZeneca PLC (LON:AZN) COVID-19 vaccine, has doubled its expectations for revenue from the contract.
The gene and cell therapy group said AstraZeneca had increased the number of batches required for the jab in the second half.
It now estimates its revenues from the vaccine will be £100mln, up from previous forecasts of £50mln.
The company s shares have jumped 128p or 12.77% to 1130p, making it the biggest riser in the FTSE 350.